Introducing Philips IntraSight interventional applications platform where imaging, physiology, co-registration* and software come together to facilitate optimal patient care. IntraSight offers a comprehensive suite of clinically proven modalities, such as, iFR/FFR, IVUS and co-registration* to simplify complex interventions, speed routine procedures and provide improved patient care.
With the most robust cybersecurity, which runs on Microsoft Windows 10, providing you with the latest data encryption and protection against cybersecurity threats.
IntraSight can scale to meet the evolving needs of your lab when new applications or modalities become available, without the need to purchase new hardware. Only Philips Interventional Applications Platform, IntraSight, offers best-in-class imaging and physiology tools with iFR, iFR Co-registration*, FFR, IVUS, IVUS Co-registration*, and Angio+*. With its modular architecture, IntraSight stays on top of latest advances and important security updates.
Optimizing lab performance with tableside touchscreen control, systems integration, data management and remote service diagnostics
IntraSight Mobile is designed for peripheral vascular and coronary procedures, operable directly from the sterile field. This is available for the hospital, office-based lab, and ambulatory surgery center environment.
The IntraSight applications platform is where imaging, physiology, co-registration* and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans. IntraSight is built on a new foundational platform designed to meet the evolving needs of your lab today and tomorrow.
IntraSight Mobile is an easy-to-use, small footprint, digital IVUS imaging and physiology system, designed for peripheral vascular and coronary procedures, operable directly from the sterile field. This is available for the hospital, office-based lab, and ambulatory surgery center environment.
Includes iFR physiology the global gold standard among resting indices with a Class IA recommendation in the ACC/AHA/SCAI and ESC Guidelines.2,3
* Co-registration tools available within IntraSight 7 configuration via SyncVision.
* Philips Mobile Interventional Applications Platform – IntraSight Mobile – is CE marked for sale in Europe and has received FDA 510(k) clearance for sale in the U.S.
[1] Co-registration tools available within IntraSight 7 configuration via SyncVision.
[2] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.
[3] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.
You are about to visit a Philips global content page
Continue